Status:
COMPLETED
The TOGETHER Project - Kidney
Lead Sponsor:
Mayo Clinic
Conditions:
Kidney Transplant Rejection
Eligibility:
All Genders
18+ years
Brief Summary
Researchers are trying to develop a way to customize immunosuppression treatment, based on the results of a blood test that measures the risk of rejection.
Eligibility Criteria
Inclusion
- Conventional solitary kidney transplant (ABO compatible, crossmatch negative, not a kidney transplant simultaneously transplanted with another non-renal organ including heart, liver, lung or pancreas)
- Patients who have given informed consent and are willing to comply with the protocol, including the use of their specimens and data for subsequent research.
Exclusion
- EBV -seronegative recipient
- ABO incompatible kidney transplants.
- Simultaneous kidney and extra-renal organ transplants including pancreas, liver, heart, lung, bone marrow transplantation, etc or prior recipient of non-renal transplant. Subjects who had previous extra renal transplants may be included in the study.
- Positive crossmatch kidney transplants (T cell crossmatch \>100, B flow cytometric crossmatch \>150).
- Participating in other clinical trials
- Any kidney transplant recipient \< 18 years of age.
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03873623
Start Date
November 1 2016
End Date
December 19 2019
Last Update
February 7 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Scottsdale, Arizona, United States, 85259
2
Mayo Clinic
Jacksonville, Florida, United States, 32224
3
Mayo Clinic
Rochester, Minnesota, United States, 55905